Alantra advises 90TEN on its sale to Envision Pharma Group
SECTORHealthcare
ServiceM&A
Alantra has advised the shareholders of 90TEN, the global healthcare communications consultancy, on the sale of the business to Envision Pharma Group. Envision Pharma Group is a global provider of evidence-based communication services and industry-leading technology solutions.
90TEN will retain its brand and service offering, bringing its insight-led behavioral science model Feel-Think-Do™ to a broad spectrum of Envision Pharma Group’s communications solutions. This partnership will enrich Envision Pharma Group’s global reach in medical affairs, which include its flagship technology, iEnvision®, together with strategic publications planning and delivery, medical strategy and communications, market access, and creative and digital solutions. In adding 90TEN’s strengths in behavioral science, creativity, and insight-driven communications, this acquisition will deliver an enhanced service offering to the Group’s global client base.
Based in London, 90TEN works with over half of the top 20 pharma companies in the world serving clients across Europe and North America. The acquisition of 90TEN will bring the total number of Envision Pharma Group employees to around 800 across 14 offices and four continents. 90TEN will be managed from its London headquarters by the existing management team, including co-founder Paul Tanner, and Managing Directors Peter Impey and Alison Doughty.
Alantra’s Healthcare team was appointed due to its significant experience of working with healthcare communications businesses, identifying strategic partners and securing investment solutions.
90TEN’s Chairman, Paul Tanner, commented, “The Alantra team took the time to truly understand our culture and values, and what we were looking for in a future partnership. They presented us with strategic options that would best fit 90TEN’s long-term aspirations and the needs of our team, company and clients. We now have a partner in Envision Pharma Group who shares our vision and values and will provide global support to accelerate our plans to extend into more markets and reach more audiences. They are the perfect strategic and cultural fit for 90TEN and we are very excited about the growth opportunities that this partnership will bring to both organisations.”
Related Transactions
-
Jul 2026
Debt Advisory – Debt Financing
Jul 2026SECTOR HealthcareService Debt Advisory -
Jun 2026
Sell-side advisory
Jun 2026SECTOR Consumer Goods & Retail; HealthcareService M&A -
Jan 2026
Sell-side advisory
Jan 2026SECTOR Consumer Goods & Retail; HealthcareService M&A -
Dec 2025
Buy-side advisory
Dec 2025SECTOR HealthcareService M&A